Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Anika's Third Quarter Earnings Conference Call. [Operator Instructions].
Anika Therapeutics Inc. (ANIK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Trigran Investments Douglas T. Granat | 2,124,460 | $52,474,161 | -1% | 5.74% |
| 2. | Renaissance Technologies Jim Simons | 574,229 | $14,183,456 | -5% | 0.02% |
| 3. | Alta Fundamental Advisers Jeremy Carton And Gilbert Li | 296,082 | $7,313,225 | 2.1% | |
| 4. | Meros Investment Management Timothy Chatard | 237,295 | $5,861,187 | +12% | 2.65% |
| 5. | Stonepine Capital Timothy P. Lynch | 189,308 | $4,675,908 | +15% | 2.95% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.37 | 1,500 | Officer | 9,867 | 2022-05-11 | Filing | |
| $26.65 | 1,500 | Officer | 8,367 | 2022-03-14 | Filing | |
| $24.66 | 2,000 | Director | 17,121 | 2022-03-11 | Filing | |
| $25.81 | 3,813 | Officer, Director | 59,992 | 2022-03-11 | Filing | |
| $25.36 | 4,287 | Officer, Director | 56,179 | 2022-03-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $42.60 | 2,000 | Director | 7,953 | 2021-05-12 | Filing | |
| $36.77 | 3,446 | Director | 9,953 | 2020-11-10 | Filing | |
| $35.15 | 1,244 | Officer | 1,756 | 2020-07-09 | Filing | |
| $42.68 | 2,700 | Director | 13,399 | 2020-02-26 | Filing | |
| $59.71 | 20,000 | Officer | 47,741 | 2019-11-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,383,877 | $31,358,653 | 0% | |
| 2. | 1,081,360 | $24,503,618 | 8.26% | |
| 3. | 821,452 | $18,614,101 | 0% | |
| 4. | 764,045 | $17,313,259 | 0% | |
| 5. | 509,522 | $11,545,769 | 0.29% |
News See All
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to Anika’s Second Quarter 2024 Earnings Conference Call.
Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript
Anika Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.30712 EPS, expectations were $-0.19. Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call Transcript
Anika Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-4.3 EPS, expectations were $-0.26.
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call Transcript
Operator: Good evening, ladies and gentlemen, and welcome to Anika's Third Quarter 2023 Earnings Conference Call. All participants' will be in a listen-only mode.
5 Recent Activist Investor Campaigns
Sleep Number, a company that offers sleep solutions and services in the United States, is also the subject of activist campaigns over deteriorating performance.
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q2 2023 Earnings Call Transcript
Operator: Good evening, ladies and gentlemen, and welcome to Anika's Second Quarter 2023 Earnings Conference Call. [Operator Instructions].
10 Oversold Small Cap Stocks To Buy
In this piece, we will take a look at the ten oversold small cap stocks to buy.
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to Anika's First Quarter 2023 Earnings Conference Call. [Operator Instructions] This call is being recorded on Tuesday, May 9, 2023.